Parthenon Therapeutics

We are a young, driven company with the passion to advance the understanding of cancer immune exclusion and resistance in a way that leads to therapies intended to make a meaningful change in the lives of cancer patients. Our values support our mission, just as our team members support each other. We are scientists, drug developers, clinicians, pathologists, bioinformaticians, engineers, innovators, and cancer warriors redefining the treatment landscape for patients with recalcitrant cancers. Incendia Therapeutics strives to provide a professional employee-friendly environment in which goal-oriented individuals thrive in meeting the challenges of our vision. Wendye is a frequent mentor to entrepreneurs, graduate students and housestaff. Travis is a practicing surgical oncologist and clinical trialist with over 13 years of oncology drug development and clinical practice experience. Laura Dillon is the Head of Translational Biomarkers, responsible for designing and implementing Incendia’s biomarker strategy. Jeff remains passionate about developing new treatment options that address the unmet medical needs for cancer patients.